drugset / Trial / NCT01714401
Nebulized Bronchodilators and Cardiac Repolarization
RandomizedParallel-groupTriple-blindOther
Summary
Patients of the ICU's often require bronchodilatory treatment due to bronchospasm caused by conditions like : acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) or asthma. The β2 adrenergic drugs are one of the most commonly used for this purpose. However it is known that they may cause tachycardia and may have substantial proarrhythmic effect. The investigators' aim is to estimate the influence of nebulized bronchodilatory drugs on selected electrophysiological parameters, whose changes are generally recognized as potentially increasing the risk of ventricular and supraventricular arrhythmias. Two drugs will be compared - salbutamol given in two doses and ipratropium bromide
Timeline
- Start
- 2012-03
- Primary completion
- 2013-05-30
- Completion
- 2013-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Salbutamol | Unknown | 2.5 mg | Inhaled |
| Comparator | Salbutamol | Unknown | 5 mg | Inhaled |
Indications
No indication recorded.